Figure 2.
Representation of the study schema. Intervention consisted of 1 PET/MR scan repeated up to 3 times after the injection of 10 mCi [18F]PARPi. Six blood draws (5 mL each) were taken: 5 to access the pharmacokinetics and distribution of the drug and 1 for complete blood count with differential and a complete metabolic panel to access toxicity. Vital signs included temperature, heart rate, blood pressure, and oxygen saturation; none were out of normal range.